Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations
…, J Lee, JMS Bartlett, DJ Slamon, MF Press - Journal of Clinical …, 2009 - ascopubs.org
The goal of this review is to systematically address a number of issues raised in the American
Society of Clinical Oncology–College of American Pathologists (ASCO-CAP) guidelines …
Society of Clinical Oncology–College of American Pathologists (ASCO-CAP) guidelines …
Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
…, DV Spicer, L Dahmoush, MF Press - Epidemiologic …, 1993 - pubmed.ncbi.nlm.nih.gov
PIP: Epidemiologic studies suggest that ovarian hormones contribute to the development of
breast cancer at all stages. Early menopause and premenopausal obesity reduces the risk …
breast cancer at all stages. Early menopause and premenopausal obesity reduces the risk …
Studies of the HER-2/neu Proto-Oncogene in Human Breast and Ovarian Cancer
…, WJ Levin, SG Stuart, J Udove, A Ullrich, MF Press - Science, 1989 - science.org
Carcinoma of the breast and ovary account for one-third of all cancers occurring in women
and together are responsible for approximately one-quarter of cancer-related deaths in …
and together are responsible for approximately one-quarter of cancer-related deaths in …
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
MF Press, L Bernstein, PA Thomas… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE The HER-2/neu gene codes for a membrane receptor protein that is homologous,
but distinct from the epidermal growth factor receptor. This investigation was performed to …
but distinct from the epidermal growth factor receptor. This investigation was performed to …
Her-2/neu Expression in Node-negative Breast Cancer: Direct Tissue Quantitation by Computerized Image Analysis and Association of Overexpression with …
MF Press, MC Pike, VR Chazin, G Hung, JA Udove… - Cancer research, 1993 - AACR
The HER-2/neu proto-oncogene (also known as c-ceb B-2) is homologous with, but distinct
from, the epidermal growth factor receptor. Amplification of this gene in node-positive breast …
from, the epidermal growth factor receptor. Amplification of this gene in node-positive breast …
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists …
…, PB Mangu, S Paik, EA Perez, MF Press… - Journal of clinical …, 2013 - ascopubs.org
Purpose To update the American Society of Clinical Oncology (ASCO)/College of American
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast …
…, S Paik, MD Pegram, EA Perez, MF Press… - Journal of clinical …, 2006 - ascopubs.org
Purpose To develop a guideline to improve the accuracy of human epidermal growth factor
receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. …
receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. …
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline …
…, W Hanna, RB Jenkins, MF Press… - … of pathology & …, 2018 - meridian.allenpress.com
Purpose.— To update key recommendations of the American Society of Clinical Oncology (ASCO)/College
of American Pathologists (CAP) human epidermal growth factor receptor 2 (…
of American Pathologists (CAP) human epidermal growth factor receptor 2 (…
[PDF][PDF] Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor–positive metastatic breast cancer
…, A Manikhas, MJ Kennedy, MF Press… - Journal of Clinical …, 2009 - breastcancer.org.nz
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor
pathways may cause endocrine resistance in breast cancer. This trial evaluated the effect …
pathways may cause endocrine resistance in breast cancer. This trial evaluated the effect …
A Big Bang model of human colorectal tumor growth
What happens in early, still undetectable human malignancies is unknown because direct
observations are impractical. Here we present and validate a'Big Bang'model, whereby …
observations are impractical. Here we present and validate a'Big Bang'model, whereby …